Connection

Konstantinos Syrigos to Tumor Suppressor Protein p53

Back to Details
This is a "connection" page, showing publications Konstantinos Syrigos has written about Tumor Suppressor Protein p53.
Konstantinos Syrigos
Connection Strength
0.038
Tumor Suppressor Protein p53
  1. Phase II study of panitumumab combined with capecitabine and oxaliplatin as first-line treatment in metastatic colorectal cancer patients: clinical results including extended tumor genotyping. Med Oncol. 2018 May 31; 35(7):101.
    View in: PubMed
    Score: 0.038
Connection Strength

The connection strength for concepts is the sum of the scores for each matching publication.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.